XP13512, A Novel Gabapentin Prodrug: 2. Improved Oral Bioavailability, Dose Proportionality, and Colonic Absorption Compared to Gabapentin in Rats and Monkeys

Kenneth C Cundy; Thamil Annamalai; Lin Bu; Josephine De Vera; Jenny Estrela; Wendy Luo; Payal Shirsat; Allan Torneros; Fenmei Yao; Joan Zou; Ronald W Barrett; Mark A Gallop

doi:10.1124/jpet.104.067959

OtherAbsorption, Distribution, Metabolism, and Excretion

XP13512, A Novel Gabapentin Prodrug: 2. Improved Oral Bioavailability, Dose Proportionality, and Colonic Absorption Compared to Gabapentin in Rats and Monkeys

Kenneth C Cundy, Thamil Annamalai, Lin Bu, Josephine De Vera, Jenny Estrela, Wendy Luo, Payal Shirsat, Allan Torneros, Fenmei Yao, Joan Zou, Ronald W Barrett and Mark A Gallop

Journal of Pharmacology and Experimental Therapeutics May 14, 2004, DOI: https://doi.org/10.1124/jpet.104.067959

Kenneth C Cundy

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Thamil Annamalai

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Lin Bu

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Josephine De Vera

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Jenny Estrela

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Wendy Luo

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Payal Shirsat

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Allan Torneros

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Fenmei Yao

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Joan Zou

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Ronald W Barrett

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Mark A Gallop

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Info & Metrics
eLetters
PDF

This is a PDF-only article. The first page of the PDF of this article appears above.

In this issue

Journal of Pharmacology and Experimental Therapeutics

Vol. 391, Issue 3

1 Dec 2024

Table of Contents
Table of Contents (PDF)
About the Cover
Index by author
Editorial Board (PDF)
Front Matter (PDF)

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following XP13512, A Novel Gabapentin Prodrug: 2. Improved Oral Bioavailability, Dose Proportionality, and Colonic Absorption Compared to Gabapentin in Rats and Monkeys

Message Subject (Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics

Message Body (Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.

Your Personal Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Citation Tools

OtherAbsorption, Distribution, Metabolism, and Excretion

XP13512, A Novel Gabapentin Prodrug: 2. Improved Oral Bioavailability, Dose Proportionality, and Colonic Absorption Compared to Gabapentin in Rats and Monkeys

Kenneth C Cundy, Thamil Annamalai, Lin Bu, Josephine De Vera, Jenny Estrela, Wendy Luo, Payal Shirsat, Allan Torneros, Fenmei Yao, Joan Zou, Ronald W Barrett and Mark A Gallop

Journal of Pharmacology and Experimental Therapeutics May 14, 2004, DOI: https://doi.org/10.1124/jpet.104.067959

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

OtherAbsorption, Distribution, Metabolism, and Excretion

XP13512, A Novel Gabapentin Prodrug: 2. Improved Oral Bioavailability, Dose Proportionality, and Colonic Absorption Compared to Gabapentin in Rats and Monkeys

Kenneth C Cundy, Thamil Annamalai, Lin Bu, Josephine De Vera, Jenny Estrela, Wendy Luo, Payal Shirsat, Allan Torneros, Fenmei Yao, Joan Zou, Ronald W Barrett and Mark A Gallop

Journal of Pharmacology and Experimental Therapeutics May 14, 2004, DOI: https://doi.org/10.1124/jpet.104.067959

Share This Article:

Tweet Widget
Facebook Like
Google Plus One

Jump to section

Article
Info & Metrics
eLetters
PDF

Main menu

User menu

Search

XP13512, A Novel Gabapentin Prodrug: 2. Improved Oral Bioavailability, Dose Proportionality, and Colonic Absorption Compared to Gabapentin in Rats and Monkeys

In this issue

XP13512, A Novel Gabapentin Prodrug: 2. Improved Oral Bioavailability, Dose Proportionality, and Colonic Absorption Compared to Gabapentin in Rats and Monkeys

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

Similar Articles

Navigate

More Information

ASPET's Other Journals